TCT 2020 | Initial Studies Show Incredible Results with Lithotripsy in Calcified Lesions

Intravascular coronary lithotripsy shows promise for the improvement of angioplasty in severely calcified lesions, according to data from the DISRUPT CAD III study, published in JACC and simultaneously presented at the TCT 2020 Congress.

Calcification in all patients enrolled was highly severe, with an average length of 48 mm, and side-branch involvement in 30% of cases.

Lithotripsy, which involves using acoustic pressure waves to fracture calcium, was well tolerated with low rates of complications.

Observed results were confirmed by pre- and post-procedure intravascular imaging.

DISRUPT CAD III enrolled 431 patients in 47 sites presenting severely calcified de novo coronary artery lesions with reference diameters between 2.5 mm and 4.0 mm.


Read also: TCT 2020 | Fewer Symptoms and Events when Optimizing with iFR.


The primary safety endpoint was observed in 92.2% of patients. Similarly, the effectiveness endpoint occurred in 92.4%. Both endpoints exceeded expectations.

Previous reports indicated the possibility of ventricular capture with shock waves, something that was observed in this study. Said captures were not associated with sustained ventricular arrhythmias during or immediately after the procedure, and they did not correlate with adverse events either.

Conclusion

Coronary lithotripsy was safe and effective in facilitating stent implantation and expansion in highly calcified lesions.

DISRUPT-CAD-III

Original Title: Intravascular lithotripsy for treatment of severely calcified coronary artery disease: the DISRUPT CAD III study.

Reference: Hill JM et al. J Am Coll Cardiol. 2020; Epub ahead of print y presentado simultáneamente en el congreso TCT 2020 virtual.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...